Abbott LabsHealthcare products company Abbott Labs (ABT 0.36%) has evolved over the years.
Eli LillyPharmaceutical giant Eli Lilly (LLY 0.18%) might be the most explosive stock of these three.
Eli Lilly is one of a small number of pharmaceutical companies with FDA-approved GLP-1 products.
Analysts believe Eli Lilly will deliver earnings growth that averages 20% annually over the next three to five years.
Look for management to ramp up that payout as Eli Lilly enjoys rapid growth over the coming years...
News articles remains the property of the source. Tellbrief is a news aggregator.